Runx2 Regulates IGalnt3/I and IFgf23/I Expressions and Galnt3 Decelerates Osteoid Mineralization by Stabilizing Fgf23

Runx2 (runt related transcription factor 2) is an essential transcription factor for osteoblast proliferation and differentiation. Uridine diphosphate (UDP)-N-acetylgalactosamine (GalNAc): polypeptide GalNAc-transferase 3 (Galnt3) prevents proteolytic processing of fibroblast growth factor 23 (Fgf23), which is a hormone that regulates the serum level of phosphorus. Runx2 and Galnt3 were expressed in osteoblasts and osteocytes, and Fgf23 expression was restricted to osteocytes in bone. Overexpression and knock-down of Runx2 upregulated and downregulated, respectively, the expressions of Galnt3 and Fgf23, and Runx2 directly regulated the transcriptional activity of Galnt3 in reporter assays. The expressions of Galnt3 and Fgf23 in osteoblast-specific Runx2 knockout (Runx2[sup.fl/flCre]) mice were about half those in Runx2[sup.fl/fl] mice. However, the serum levels of phosphorus and intact Fgf23 in Runx2[sup.fl/flCre] mice were similar to those in Runx2[sup.fl/fl] mice. The trabecular bone volume was increased during aging in both male and female Galnt3[sup.−/−] mice, but the osteoid was reduced. The markers for bone formation and resorption in Galnt3[sup.−/−] mice were similar to the control in both sexes. Galnt3[sup.−/−] mice exhibited hyperphosphatemia and hypercalcemia, and the intact Fgf23 was about 40% that of wild-type mice. These findings indicated that Runx2 regulates the expressions of Galnt3 and Fgf23 and that Galnt3 decelerates the mineralization of osteoid by stabilizing Fgf23.